156 filings
Page 5 of 8
8-K
9fm8 cux2w5w
26 Feb 19
Akcea Reports Financial Results and Highlights for Fourth
4:16pm
8-K
v7ozg
25 Feb 19
Entry into a Material Definitive Agreement
6:06am
S-8
0r5uio6l0w2jr6w
21 Dec 18
Registration of securities for employees
4:07pm
CT ORDER
07ppiqeyro
18 Dec 18
Confidential treatment order
3:29pm
DEF 14C
muzkczp09
28 Nov 18
Information statement
4:22pm
8-K
j5lte12i
23 Nov 18
Departure of Directors or Certain Officers
4:38pm
8-K
6fi7qrpq5hsydk865
5 Nov 18
Akcea Reports Financial Results and Highlights for Third Quarter 2018
4:16pm
8-K
5u6lden5 h3g
9 Oct 18
Akcea Announces Changes to Board of Directors
7:00am
8-K
wjrn66v6uohi 10
9 Oct 18
Other Events
12:00am
S-3ASR
5lr1 du4mpviwqbd
18 Sep 18
Automatic shelf registration
12:00am
8-K
x61q833
18 Sep 18
Other Events
12:00am
8-K
3ibg30fp19 lhnuru
6 Sep 18
Cost Associated with Exit or Disposal Activities
12:00am
8-K
arthd a4o
27 Aug 18
Akcea and Ionis Receive Complete Response Letter for WAYLIVRA from FDA
12:00am
8-K
8q9nf cirtq
6 Aug 18
Akcea Reports Financial Results and Highlights for Second Quarter 2018
4:15pm
8-K
e51cdnm
2 Aug 18
Entry into a Material Definitive Agreement
8:17am
8-K
odrj0z5 xerywni
11 Jul 18
Akcea and Ionis Announce Approval of TEGSEDIā¢ (inotersen) in the European Union
9:36pm
S-8
xn1vvce21cyah1ql
20 Jun 18
Registration of securities for employees
12:00am